Business Wire

Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

− GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Now Available by Prescription for Intravenous or Subcutaneous Use in People Aged ...
Business Insider

CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI)

PHILADELPHIA, April 21, 2020 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that a clinical study examining faster infusion rates and higher volumes than currently approved ...
Monthly Prescribing Reference

Immune Globulins

The following is a list of immune globulins (IG) specifically for the treatment of primary immune deficiency. 1,2 1 Congenital or X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott ...
Medical News Today

Gammagard Liquid infusion

Gammagard Liquid is a brand-name infusion prescribed for certain rare immune conditions. Gammagard Liquid contains the active ingredient immune globulin (human). Gammagard Liquid has boxed warnings. A ...
EurekAlert!

Octapharma USA research at AAAAI: cutaquig® study at higher infusion rates presented

image: Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting evaluating the efficacy and safety of cutaquig® (Immune Globulin Subcutaneous ...
Nasdaq

Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin ...
Seeking Alpha

HyHub™ and HyHub™ Duo Devices Now Available in the U.S. to Simplify HYQVIA® Infusion Preparation

Dedicated Devices for HYQVIA [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Reduce the Number of Steps and Ancillary Supplies Compared to a Pooling Bag When Preparing the ...
inforum

Shortage leaves people without lifesaving drug for cancer, epilepsy, immune disorders

A severe shortage of immune globulin - a popular medicine used to treat epilepsy, cancer and immune disorders - is forcing doctors nationwide to cancel patients' lifesaving infusions as hospitals and ...
Yahoo

Shortage of life-saving drug leaves immune-deficient patients in 'terrifying' spot: 'no replacement'

After enduring extensive fertilization treatment and several difficult pregnancies, including a miscarriage and a stillbirth, Illinois law professor Sonia Green eventually grew the family she had so ...
Business Wire

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1

“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...